{"id":12761,"title":"TheBizLounge Mystic drug failure hurts AstraZeneca plus meet the US Govt’s new press boy","publisher":"Share Talk","author":"sharetalk","published":"2017-07-27T15:48:59+00:00","modified":"2017-08-01T07:43:30+00:00","canonical_url":"https://www.share-talk.com/thebizlounge-mystic-drug-failure-hurts-astrazeneca-plus-meet-the-us-govts-new-press-boy/","markdown_url":"https://www.share-talk.com/thebizlounge-mystic-drug-failure-hurts-astrazeneca-plus-meet-the-us-govts-new-press-boy.md","json_url":"https://www.share-talk.com/thebizlounge-mystic-drug-failure-hurts-astrazeneca-plus-meet-the-us-govts-new-press-boy.json","category":"TheBizLounge","categories":["TheBizLounge"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"![](https://www.share-talk.com/wp-content/uploads/2017/07/Screen-Shot-2017-07-27-at-16.45.55-1024x522.png)\n\nMystic failure sends AstraZeneca shares into free fall, but could it be a good buying opportunity? And The White House’s new press boy gives a surreal and very entertaining interview to BBC’s Newsnight"}